Skip to content

A Multiple-Ascending-Dose Study of MK-4318 in Healthy Participants

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-507512-12-00
Acronym
MK-4318-002
Enrollment
32
Registered
2023-11-09
Start date
2023-11-16
Completion date
2024-03-20
Last updated
2023-12-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Interventions

None listed

Sponsors

Merck Sharp & Dohme LLC
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Belgium

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026